Hyaluronic acid from bluefin tuna by-product : Structural analysis and pharmacological activities
Copyright © 2024 Elsevier B.V. All rights reserved..
The fishing and aquaculture industries generate a huge amount of waste during processing and preservation operations, especially those of tuna. Recovering these by-products is a major economic and environmental challenge for manufacturers seeking to produce new active biomolecules of interest. A new hyaluronic acid was extracted from bluefin tuna's vitreous humour to assess its antioxidant and pharmacological activities. The characterization by infrared spectroscopy (FT-IR), nuclear magnetic resonance ((1D1H) and 2D (1H COSY, 1H/13C HSQC)) and size exclusion chromatography (SEC/MALS/DRI/VD) revealed that the extracted polysaccharide was a hyaluronic acid with high uronic acid content (55.8 %) and a weight average molecular weight of 888 kDa. This polymer possesses significant anti-radical activity and ferrous chelating capacity. In addition, pharmacological evaluation of its anti-inflammatory and analgesic potential, using preclinical models, in comparison with reference drugs (Dexamethasone, diclofenac, and acetylsalicylate of lysine), revealed promising anti-inflammatory activity as well as interesting peripheral and central antinociceptive activity. Therefore, our new hyaluronic acid compound may therefore serve as a potential drug candidate for the treatment of pain sensation and inflammation of various pathological origins.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:264 |
|---|---|
| Enthalten in: |
International journal of biological macromolecules - 264(2024), Pt 1 vom: 28. Apr., Seite 130424 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Elhiss, Sawsen [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
9004-61-9 |
|---|
| Anmerkungen: |
Date Completed 08.04.2024 Date Revised 08.04.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.ijbiomac.2024.130424 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM369186532 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM369186532 | ||
| 003 | DE-627 | ||
| 005 | 20240408232514.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240302s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ijbiomac.2024.130424 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1369.xml |
| 035 | |a (DE-627)NLM369186532 | ||
| 035 | |a (NLM)38428772 | ||
| 035 | |a (PII)S0141-8130(24)01227-3 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Elhiss, Sawsen |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Hyaluronic acid from bluefin tuna by-product |b Structural analysis and pharmacological activities |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 08.04.2024 | ||
| 500 | |a Date Revised 08.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2024 Elsevier B.V. All rights reserved. | ||
| 520 | |a The fishing and aquaculture industries generate a huge amount of waste during processing and preservation operations, especially those of tuna. Recovering these by-products is a major economic and environmental challenge for manufacturers seeking to produce new active biomolecules of interest. A new hyaluronic acid was extracted from bluefin tuna's vitreous humour to assess its antioxidant and pharmacological activities. The characterization by infrared spectroscopy (FT-IR), nuclear magnetic resonance ((1D1H) and 2D (1H COSY, 1H/13C HSQC)) and size exclusion chromatography (SEC/MALS/DRI/VD) revealed that the extracted polysaccharide was a hyaluronic acid with high uronic acid content (55.8 %) and a weight average molecular weight of 888 kDa. This polymer possesses significant anti-radical activity and ferrous chelating capacity. In addition, pharmacological evaluation of its anti-inflammatory and analgesic potential, using preclinical models, in comparison with reference drugs (Dexamethasone, diclofenac, and acetylsalicylate of lysine), revealed promising anti-inflammatory activity as well as interesting peripheral and central antinociceptive activity. Therefore, our new hyaluronic acid compound may therefore serve as a potential drug candidate for the treatment of pain sensation and inflammation of various pathological origins | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Antioxidant property | |
| 650 | 4 | |a Hyaluronic acid | |
| 650 | 4 | |a Marine waste | |
| 650 | 4 | |a Pharmacological activities | |
| 650 | 4 | |a SEC/MALS/DRI/VD | |
| 650 | 4 | |a Vitreous humour | |
| 650 | 7 | |a Hyaluronic Acid |2 NLM | |
| 650 | 7 | |a 9004-61-9 |2 NLM | |
| 650 | 7 | |a Polysaccharides |2 NLM | |
| 650 | 7 | |a Anti-Inflammatory Agents |2 NLM | |
| 700 | 1 | |a Hamdi, Assia |e verfasserin |4 aut | |
| 700 | 1 | |a Chahed, Latifa |e verfasserin |4 aut | |
| 700 | 1 | |a Boisson-Vidal, Catherine |e verfasserin |4 aut | |
| 700 | 1 | |a Majdoub, Hatem |e verfasserin |4 aut | |
| 700 | 1 | |a Bouchemal, Nadia |e verfasserin |4 aut | |
| 700 | 1 | |a Laschet, Jamila |e verfasserin |4 aut | |
| 700 | 1 | |a Kraiem, Jamil |e verfasserin |4 aut | |
| 700 | 1 | |a Le Cerf, Didier |e verfasserin |4 aut | |
| 700 | 1 | |a Maaroufi, Raoui Mounir |e verfasserin |4 aut | |
| 700 | 1 | |a Chaubet, Frédéric |e verfasserin |4 aut | |
| 700 | 1 | |a Ben Mansour, Mohamed |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t International journal of biological macromolecules |d 1992 |g 264(2024), Pt 1 vom: 28. Apr., Seite 130424 |w (DE-627)NLM012627356 |x 1879-0003 |7 nnns |
| 773 | 1 | 8 | |g volume:264 |g year:2024 |g number:Pt 1 |g day:28 |g month:04 |g pages:130424 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.ijbiomac.2024.130424 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 264 |j 2024 |e Pt 1 |b 28 |c 04 |h 130424 | ||